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T h e c l i n i c a l v a r i a b i l i t y o f 
neu rocys t i ce rcos i s is d u e to a series of f ac to r s 
such as n u m b e r , l o c a t i o n , f o r m , d i m e n s i o n s 
a n d s tage of d e v e l o p m e n t of the p a r a s i t e , the 
n a t u r e of its a c t i on o n the o r g a n i s m a n d the 
ind iv idua l i m m u n o l o g i c a l r e s p o n s e of the 
hosu .4 ,6 . T h u s , d i a g n o s i s is very d i f f i c u l t , 
especial ly in no t highly e n d e m i c a r ea s or in 
r eg ions were l a b o r a t o r y s u p p o r t is l a c k i n g . 
A n o t h e r i m p o r t a n t f e a t u r e to be c o n s i d e r e d in 
the a p p r o a c h to neu rocys t i ce r cos i s is t he lack of 
a n a l t e r n a t i v e p r o g r a m o f a n t i p a r a s i t i c 
t r e a t m e n t . T h e h igh coas t of t r e a t m e n t wi th 
p r a z i q u a n t e l a n d t h e s i d e e f f e c t s ' o f 
c o r t i c o s t e r o i d s 5 a r e fac tors that h a v e led to the 
search for new t r e a t m e n t p r o g r a m s . 
A l b e n d a z o l e , a d r u g b e l o n g i n g to the 
b e n z i m i d a z o l e g r o u p , is c h a r a c t e r i z e d by high 
t h e r a p e u t i c i n d i c e s a s a p o l y v a l e n t a n t i -
he lmin t i c agent 1* a n d wi th efficacy in p a t i e n t s 
with h y d a t i c c y s t s 7 . D e x t r o c h l o r o p h e n i r a m i n e 
is a p o t e n t a n t i - h i s t a m i n i c w i t h g o o d 
p e n e t r a t i o n in the cen t r a l n e r v o u s sys tem which 
ac t s on c e r e b r a l h i s t a m i n e r e c e p t o r s by a 
c o m p e t i t i v e m e c h a n i s m 2 . 
T h e ob jec t ive of the p r e s e n t r e sea rch was 
to e v a l u a t e for the first t i m e the t h e r a p e u t i c 
a c t i o n of a l b e n d a z o l e in c o m b i n a t i o n wi th 
d e x t r o c h l o r o p h e n i r a m i n e in p a t i e n t s w i t h 
cys t i ce rcos i s . 
F o u r t y p a t i e n t s w e r e t r e a t e d o n t h e 
In fec t ious a n d P a r a s i t i c Diseases a n d on the 
N e u r o l o g y w a r d of the Univers i ty H o s p i t a l , 
Facu l ty of M e d i c i n e of B o t u c a t u , U N E S P , 
f rom S e p t e m b e r 1984 to D e c e m b e r 1987. Three 
cl inical t r e a t m e n t g r o u p s were f o r m e d : 
G r o u p 1: 10 t o 15 m g / k g / d a y o f 
a l b e n d a z o l e by o ra l r o u t e in two series of 28 
days e a c h ; 
G r o u p 11: 15 to 25 m g / k g / d a y , in t h r ee 
series of 21 d a y s e a c h ; 
G r o u p I I I : 15 to 30 m g / k g / d a y , in t w o 
series of 21 a n d 30 d a y s . All of the p a t i e n t s in 
the t h r ee g r o u p s a l so received u n i n t e r r u p t e d l y 
18 m g / d a y d e x t r o c h l o r o p h e n i r a m i n e 
a d m i n i s t e r e d o ra l ly , d u r i n g a n d 4 to 6 m o n t h s 
a f te r the end of t r e a t m e n t . 
Al l p a t i e n t s w e r e e v a l u a t e d by c l in ica l 
e x a m i n a t i o n a n d l a b o r a t o r y t es t s , d u r i n g a n d 
i m m e d i a t e l l y a f t e r , as well as 5 to 20 m o n t h s 
af ter t he e n d of t r e a t m e n t . All p o t e n t i a l l y 
ferti le w o m e n were s u b m i t t e d to p r e g n a n c y 
t e s t s b e f o r e a n d d u r i n g t r e a t m e n t w i t h 
a l b e n d a z o l e . T h e e th ica l n o r m s of He l s ink i 
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Treaty were strictly obeyed for all o f the 
participants in the three groups . 
The fo l lowing parameters were used to 
evaluate the treatment schedule used: 
Clinical: r e m i s s i o n o f c l i n i c a l 
m a n i f e s t a t i o n s , a s i n d i c a t e d by the 
disappearance o f s y m p t o m s , by the improve o f 
the neurological examination and o f the quality of 
life. The latter was a lso evaluated quantitatively 
by attributing scores to the different types , as 
fo l lows: death = 0; great l imitat ions = 1; 
medium l imitations = 2; small l imitations = 3 
and normal life = 4. 
Laboratory tests: realized to detect s o m e 
side effects of the drug: comple te h e m o g r a m ; 
m e a s u r e m e n t s o f b l o o d g l u c o s e , a m i n o 
transferase, bi l irubins, prote ins , mucoprote ins , 
uric acid; urea, creat inine and electrolytes 
( C a + *, N a * and K + )- Fecal parasi to logy and 
urinalysis were a lso included in the protoco l . 
Cerebrospinal fluid (CSF): normal izat ion 
or at least improve o f the CSF analysis by the 
realization of tests for the presence o f anti-
cysticercum ant ibodies , g lucose , protein and 
chloride measurements , cellularity and protein 
e lectrophoresis . Punctures were performed at 
the suboccipital levels in all pat ients . 
Tomography (CT): decrease o f the number 
a n d / o r size of cysts , e d e m a , hydrocephalus and 
the increase or appearance o f the number o f 
calc i f icat ions . 
Pat ients were a lso further classified as 
having the benign , moderate or serious form of 
the disease . Benign cases were considered t o be 
t h o s e p a t i e n t s w h o d i d n o t p r e s e n t 
hydrocephalus , alterations in consc ience , or 
localizing neurological signs and w h o had no 
intracranial hypertension or only benign intra-
c r a n i a l h y p e r t e n s i o n , h e a d a c h e a n d / o r 
dizziness with pyramidal l iberation. Moderate ly 
ill patients were those w h o presented convuls ive 
seizures o f difficult contro l , w h o progressed to 
a condi t ion o f "status ep i lept icus" or w h o had 
local iz ing neurological s igns , meningit is or 
meningoencephal i t i s . Serious cases were those 
of patients presenting hydrocephalus or serious 
intracranial hypertens ion , or disturbances o f 
consc ience associated or not with localizing 
neurological s igns. A m o n g these were two 
patients with mult iple racemose cysticercosis . 
The results are s h o w e d in table 1. 
Of the 40 patients with neurocyst icercosis 
treated with a lbendazo le , 32 (80 .0%) improved , 
whereas 4 (10 .0%) remained unchanged , and 
4 ( 1 0 . 0 % ) died. Of the four patients who died, 
t w o h a d r a c e m o s e c y s t i c e r c o s i s . T h e
tomographic alterations were observed after an 
average o f 6 m o n t h s after the end of treatment 
in 23 of the 40 patients (Figure 1). 
The best results in terms o f neurological 
manifestat ions were observed in patients with 
benign and moderate forms o f cysticercosis , 
i .e . those patients w h o showed epileptic
s y n d r o m , benign intracranial hypertens ion,
headache a n d / o r dizziness with pyramidal 
l iberation, meningit is or meningoencephal i t i s . 
The results reported by the various authors 
w h o used praziquantel in the treatment of 
cysticercosis are not uniform ' .3 .». It should be 
pointed out that neurocyst icercosis is frequent 
in the rural zone in Brazil, where it mainly 
at tacks low s o c i o e c o n o m i c - l e v e l indiv iduals
w h o have difficulty in acquiring this drug 
because o f its high cost . 
T h e c o m b i n a t i o n o f a l b e n d a z o l e and 
dextrochloropheniramine seems to represent a 
v a l u a b l e a l ternat ive t rea tment o p t i o n . W e 
emphas ize that each case should be analyzed 
individually in terms o f surgical procedures , 
s y m p t o m - r e l i e v i n g m e d i c a t i o n a n d spec i f i c 
c h e m o t h e r a p y , and the possibi l i ty o f relapses 
are high for patients w h o cont inue to live under 
the same precarious hygiene condi t ions . 
TABLE 1 
Percentage of satisfactory results from neurological manifestat ion, qual i ty of life CT scan and CSF 
analysis, according to the t r e a tmen t groups. 
Pat ients Neurological Qual i ty CT scan CSF 
( N ? ) manifestat ion of life 
G r o u p I 8 50 .0% 62 .5% 71.4% 4 1 . 1 % 
G r o u p II 13 8 3 . 3 % 75.0% 71.4% 54.9% 
G r o u p III 19 94 .7% 94 .7% 77.8% 60 .3% 
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